Iridex Comments on Changing Glaucoma Reimbursement Landscape [Yahoo! Finance]
IRIDEX Corporation (IRIX)
Last iridex corporation earnings: 3/12 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
phx.corporate-ir.net/phoenix.zhtml?c=112360&p=irol-irhome
Company Research
Source: Yahoo! Finance
even coincident to MIGS procedures. (Source: Kevin LaMarche, Iridex's Senior Director of Clinical Affairs) The LCD appears designed to end the practice of stacking one form of treatment on top of another, and physicians will increasingly look for non-MIGS procedures, such as Iridex's MicroPulse and Continuous Wave TLT, as they seek to mitigate progression of the disease. (Source: Patrick Mercer, Iridex's CEO) The final LCD, L37531, provides the following reimbursement limitations: MIGS is not considered a first line treatment for mild-moderate glaucoma; a combination of a surgical MIGS procedure and an aqueous shunt cannot be performed at the same time of service in the same eye; and phacoemulsification/intraocular lens placement performed with a combination of MIGS procedures at the same time of service in the same eye is non-covered. (Source: Iridex Corporation's press release) The new LCD clarifies that treatments performed using Iridex's laser consoles and probes are not MIG
Show less
Read more
Impact Snapshot
Event Time:
IRIX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IRIX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IRIX alerts
High impacting IRIDEX Corporation news events
Weekly update
A roundup of the hottest topics
IRIX
News
- IRIDEX Co. (NASDAQ: IRIX) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Iridex Announces Milestone Five-Year Study Confirms the Long-Term Effectiveness and Safety of MicroPulse Transscleral Cyclophotocoagulation for Glaucoma ManagementGlobeNewswire
- Ophthalmic Lasers Market, Competitive Landscape and Market Forecasts to 2030 [Yahoo! Finance]Yahoo! Finance
- IRIDEX Co. (NASDAQ: IRIX) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- IRIDEX Co. (NASDAQ: IRIX) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
IRIX
Earnings
- 8/8/24 - Miss
IRIX
Sec Filings
- 11/26/24 - Form 8-K
- 11/26/24 - Form 8-K/A
- 11/13/24 - Form 8-K
- IRIX's page on the SEC website